Pharmacy Technicians on the Road to Regulation Focus on ...

laws & regulations
Drug and Pharmacies Regulation Act (DPRA) * s
December 15, 2009
Regulations to the DPRA:
Regulation 545 – Child Resistant Packages
Regulation 297/96 Amended to O.Reg. 173/08
Regulation 551 Amended to O.Reg. 172/08
Drug Schedules **
Summary of Laws
June 2007 OCP
National Drug Schedules (NAPRA)
March 17, 2010 (or later)
NDSAC Meeting – June 2010
Request for Unscheduled status for polyethylene glycol 3350
indicated for occasional constipation
Scheduling status finalized by NDSAC – April 2010
Diclofenac diethylamine in preparations for topical use on the skin
in concentrations of not more than the equivalent of 1% diclofenac
– Unscheduled (from Schedule III). Final approval of the initial
recommendation was made by NAPRA’s Executive Committee, in
consideration of comments received during the 30-day review period.
The National Drug Schedules will be revised accordingly.
Regulated Health Professions Act (RHPA) * s
December 15, 2009
Regulations to the RHPA:
Regulation 39/02 - Amended to O.Reg. 666/05
Regulation 107/96 – Amended to O.Reg. 97/10
Regulation 59/94 – Funding for Therapy or Counseling for Patients
Sexually Abused by Members
<strong>Pharmacy</strong> Act (PA) & Regulations * s
December 15, 2009
Regulations to the PA:
Regulation 202/94 Amended to O.Reg. 270/04
Regulation 681/93 Amended to O.Reg. 122/97
Standards of Practice s
Model Standards of Pratice, effective January 1, 2010
Standards of Practice for Pharmacists, 2003
Standards of Practice for <strong>Pharmacy</strong> Managers, 2005
Standards for Pharmacists Providing Services to Licensed
LTC Facilities, 2007.
Drug Interchangeability and Dispensing Fee Act (DIDFA)
& Regulations * s
June 2007
Regulations to the DIDFA:
Regulation 935 Amended to O.Reg. 354/08
Regulation 936 Amended to O.Reg. 205/96
Ontario Drug Benefit Act (ODBA) & Regulations * s
March 15, 2010
Regulations to the ODBA:
Regulation 201/96 Amended to O.Reg. 104/10
Controlled Drugs and Substances Act (CDSA) &
Regulations ** '
Act current to March 31, 2010
All regulations current to March 31, 2010
Benzodiazepines and Other Targeted Substances Regulations
Marihuana Medical Access Regulations
Narcotic Control Regulations
Precursor Control Regulations
Regulations Exempting Certain Precursors and Controlled Substances
from the Application of the Controlled Drugs and Substances Act
Food and Drugs Act (FDA) & Regulations ** '
Act current to March 31, 2010
All regulations current to March 31, 2010
Cosmetic Regulations
Food and Drug Regulations
Marijuana Exemption (FDA) Regulations
Medical Devices Regulations
Natural Health Products Regulations
Processing and Distribution of Semen for Assisted Conception
Regulations
Safety of Human Cells, Tissues and organs for transplantation
Regulations
To Schedule F: Pre-notifications
Project #1621 Addition of Dirlotapide, Firocoxib, Ibafloxacin and
Maripotant and its salts (Feb 2010)
Project #1624 Addition of Eculizumab, Olmesartan medoxomil,
Romiplostim, Ustekinumab (Jan 2010)
Project #1652 Notice of Intent to Amend Schedule F (L-asparaginase)
(Dec 2009)
Project #1659 Addition of Dronedarone (Dec 2009)
Project #1659 Addition of Medicinal Degarelix (Dec 2009)
Project #1659 Addition of Clofarabine (Dec 2009)
Project #1659 Addition of Ingredient Azacitidine (Dec 2009)
Project #1659 Addition of Urokinase (Dec 2009)
Project #1658 Addition of Doripenem and its salts and derivatives
(Dec 2009)
Project #1658 Addition of Besifloxacin and its salts (Dec 2009)
Project #1658 Addition of Alitretinoin and its salts and derivatives
(Dec 2009)
Project #1658 Addition of Saxagliptin and its salts (Dec 2009)
OCP By-Law No. 2 – March 2010 s
OCP By-Laws – December 2006
Schedule A: Code of Ethics for members
Schedule B: “Code of Conduct” and Procedures for Council and
Committee members.
Reference s
OCP Required Reference Guide for Pharmacies in
Ontario, January 2010
* Information available at Publications Ontario (416) 326-5300 or 1-800-668-9938 www.e-laws.gov.on.ca
** Information available at www.napra.org
' Information available at Federal Publications Inc. Ottawa: 1-888-4FEDPUB (1-888-433-3782)
Toronto: Tel: (416) 860-1611 • Fax: (416) 860-1608 • e-mail: info@fedpubs.com
s Information available at www.ocpinfo.com
pharmacyconnection • May/June 2010
31